URINARY BLADDER CANCER
Clinical trials for URINARY BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER CANCER trials appear
Sign up with your email to follow new studies for URINARY BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo aims to shrink bladder tumors before surgery
Disease control Not yet recruitingThis study tests whether combining two drugs (trastuzumab rezetecan and camrelizumab) before surgery can improve outcomes for people with a certain type of muscle-invasive bladder cancer (HER2-positive). About 44 adults will receive the treatment to see if it helps eliminate canc…
Matched conditions: URINARY BLADDER CANCER
Phase: PHASE2 • Sponsor: Sheng Tai • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New program aims to protect cancer Patients' hearts during treatment
Disease control Not yet recruitingThis study looks at whether a special program called Primary Care Connect (PC2) helps cancer survivors who also have conditions like high blood pressure, diabetes, or high cholesterol keep their heart risks under control during cancer treatment. About 266 adults with early-stage …
Matched conditions: URINARY BLADDER CANCER
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Bladder cancer: can faster chemo before surgery boost cure rates?
Disease control Not yet recruitingThis phase 2 trial tests a dose-dense (faster) schedule of two chemotherapy drugs, gemcitabine and cisplatin, given before surgery for muscle-invasive bladder cancer. The goal is to see if this approach can completely eliminate the tumor in the bladder and lymph nodes. Thirty eli…
Matched conditions: URINARY BLADDER CANCER
Phase: PHASE2 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 26, 2026 19:10 UTC